ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
Author:
Publisher
Proceedings of the National Academy of Sciences
Subject
Multidisciplinary
Reference48 articles.
1. ErbB receptors and signaling pathways in cancer
2. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
3. Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
4. The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
5. An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor
Cited by 379 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs;Acta Pharmacologica Sinica;2024-01-10
2. CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway;Life Sciences;2024-01
3. HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies;Journal of Thoracic Oncology;2024-01
4. Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes;Cell Reports;2024-01
5. Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications;Cells;2023-12-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3